miR-148b-5p regulates hypercalciuria and calcium-containing nephrolithiasis
Calcium-containing stones represent the most common form of kidney calculi, frequently linked to idiopathic hypercalciuria, though their precise pathogenesis remains elusive. This research aimed to elucidate the molecular mechanisms involved by employing urinary exosomal microRNAs as proxies for renal tissue analysis. Elevated miR-148b-5p levels were observed in exosomes derived from patients with kidney stones. Systemic administration of miR-148b-5p in rat models resulted in heightened urinary calcium excretion, whereas its inhibition reduced stone formation. RNA immunoprecipitation combined with deep sequencing identified miR-148b-5p as a suppressor of calcitonin receptor (Calcr) expression, thereby promoting urinary calcium excretion and stone formation. Mice deficient in Calcr in distal epithelial cells demonstrated elevated urinary calcium excretion and renal calcification. Mechanistically, miR-148b-5p regulated Calcr through the circRNA-83536/miR-24-3p signaling pathway. Human kidney tissue samples corroborated these results. In summary, miR-148b-5p regulates the formation of calcium-containing kidney stones via the circRNA-83536/miR-24-3p/Calcr axis, presenting a potential target for novel therapeutic interventions to prevent calcium nephrolithiasis.
Authors
- Guohua Zeng (ORCID: https://orcid.org/0000-0002-3110-8933)
- Ruiyue Zhao (ORCID: https://orcid.org/0000-0001-5242-0785)
- Zhicong Huang
- Wei Zhu (ORCID: https://orcid.org/0000-0002-5744-5962)
- Jian Zhong (ORCID: https://orcid.org/0000-0001-7157-603X)
- Yin Sun (ORCID: https://orcid.org/0009-0000-8793-3169)
- Zhen Zhou
- Zhijian Zhao (ORCID: https://orcid.org/0000-0001-5988-7599)
- Chengjie Wu
- Guoyao Ai
- Yang Liu (ORCID: https://orcid.org/0000-0001-9971-8191)
- Weijie Liu (ORCID: https://orcid.org/0000-0002-8023-9913)
- Xinlu Wang (ORCID: https://orcid.org/0000-0003-1997-5687)
- Shusheng Liu (ORCID: https://orcid.org/0000-0002-8760-5090)
- Wen Zhong (ORCID: https://orcid.org/0000-0003-0540-7195)
- Xuliang Pang
- Lianmin Luo
Institutions
- University of Rochester Medical Center (US)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Nanfang Hospital (CN)
- Second Hospital of Tianjin Medical University (CN)
- Tianjin Medical University (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Cellular and Molecular Life Sciences
- Published
- 2024-08-25
- DOI
- https://doi.org/10.1007/s00018-024-05408-8
- Citations
- 8
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.35
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- National Key Research and Development Program of China